{"study_id": 80758, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of melatonin in regulating circadian rhythms and its potential influence on metabolic disturbances, particularly in the context of type 2 diabetes mellitus (T2DM).", "results_summary": "The study found that melatonin may help regulate insulin secretion and protect pancreatic \u03b2-cells from oxidative stress, suggesting a potential role in managing T2DM and related metabolic disorders. Genetic associations between MT2 receptor SNPs and T2DM risk were also highlighted.", "population_specificity": "General discussion on circadian rhythms and metabolic diseases, not specific to a particular population.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:22.745843+00:00"}
{"study_id": 80757, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to determine whether a 12-week physical activity intervention could improve sleep quality or melatonin levels in children with autism spectrum disorders (ASD).", "results_summary": "The abstract describes a study protocol but does not report results regarding melatonin's effects, as the study was still ongoing at the time of the abstract's submission.", "population_specificity": "Children with autism spectrum disorders (ASD).", "effective_dosage": "Not specified.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:22.747172+00:00"}
{"study_id": 80761, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the evidence for the benefits and risks of currently available pharmacological treatments for chronic low back pain, including paracetamol, NSAIDs, muscle relaxants, antidepressants, anticonvulsants, opioids, and other drugs.", "results_summary": "The study found that pharmacological treatments for chronic low back pain generally have small to moderate and short-lasting effects on pain reduction and functional improvement compared to placebo, with various side effects, particularly serious ones associated with prolonged opioid use.", "population_specificity": "Patients with chronic low back pain.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:28.292747+00:00"}
{"study_id": 80760, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether ramelteon, a melatonin agonist, could prevent delirium and reduce ICU stay duration in critically ill patients.", "results_summary": "Ramelteon showed a trend toward reducing ICU stay duration and significantly decreased both the occurrence rate and duration of delirium. Nonintubated patients in the ramelteon group also experienced fewer nighttime awakenings.", "population_specificity": "Critically ill ICU patients who could take medicines orally or via nasogastric tube within the first 48 hours of admission.", "effective_dosage": "8 mg/d administered at 20:00 hours daily.", "study_duration": "Until discharge from the ICU.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:29.046691+00:00"}
{"study_id": 80762, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the signaling pathways involved in melatonin-induced cardioprotection, particularly its potential to protect the heart against ischemia/reperfusion damage.", "results_summary": "The study highlights melatonin's role in activating protective pathways such as RISK, SAFE, Notch, sirtuins, Nrf2, and TOM70, with a focus on mitochondrial involvement in cardioprotection. It also briefly discusses the current status of melatonin's clinical applications in humans.", "population_specificity": "Not specified (review article, not a clinical study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:29.099236+00:00"}
{"study_id": 80764, "supplement_id": 1328, "safety_score": "100", "efficacy_score": 90, "quality_score": 85, "study_goal": "To evaluate the clinical efficacy of melatonin in treating delirium caused by acute organophosphorus pesticide poisoning (AOPP).", "results_summary": "Melatonin significantly improved outcomes in AOPP-induced delirium, with an excellence rate of 82.75% in the melatonin group compared to 30.00% in the placebo group (p < 0.01). No adverse events were reported.", "population_specificity": "59 AOPP patients with subsequent delirium.", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:29.100325+00:00"}
{"study_id": 80763, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the signaling pathways involved in idiopathic pulmonary fibrosis (IPF) and explore the potential protective effects of melatonin on these pathways.", "results_summary": "The study suggests melatonin and its metabolites act as broad-spectrum antioxidants, modulating molecular pathways involved in IPF by scavenging reactive species and upregulating endogenous antioxidants. However, the abstract does not provide specific clinical outcomes or statistical evidence of melatonin's efficacy in IPF treatment.", "population_specificity": "Not specified (review of molecular pathways, not a clinical trial).", "effective_dosage": "Not available.", "study_duration": "Not available.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:30.705470+00:00"}
{"study_id": 80767, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether melatonin could counteract the inhibitory effects of BMP-6 on progesterone production in granulosa cells, potentially preserving ovarian function.", "results_summary": "Melatonin treatment impaired BMP-6's inhibition of FSH-induced progesterone production and suppressed BMP-6-induced Smad signaling in granulosa cells, suggesting a regulatory role in BMP receptor signaling. This indicates melatonin may help maintain progesterone production by suppressing BMP-6 signaling, particularly relevant in conditions like polycystic ovary syndrome.", "population_specificity": "Granulosa cells (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:30.833329+00:00"}
{"study_id": 80766, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to review the interactions between circadian rhythms and multiple sclerosis, as well as explore the potential benefits of chronotherapy, including immunomodulatory drugs like Melatonin, to enhance treatment efficacy and reduce side effects.", "results_summary": "The study highlights the bidirectional link between circadian rhythms and the immune system, suggesting that disruption of these rhythms can impact disease pathology and quality of life. It proposes chronotherapy as a method to improve treatment outcomes and minimize adverse effects in conditions like multiple sclerosis.", "population_specificity": "Preclinical and clinical literature, including studies on multiple sclerosis and its animal model, experimental autoimmune encephalomyelitis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:31.186309+00:00"}
{"study_id": 80765, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to determine whether Melatonin was effective and safe for treating antipsychotic-induced tardive dyskinesia in people with chronic mental illnesses.", "results_summary": "The study found low- to very low-certainty evidence of no difference between Melatonin and placebo or no treatment in improving tardive dyskinesia symptoms (RR 0.89, 95% CI 0.71 to 1.12, 2 RCTs, n = 32). The results were inconclusive due to small sample sizes and limited data.", "population_specificity": "Adults with chronic psychiatric disorders, mostly schizophrenia, and antipsychotic-induced tardive dyskinesia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:31.204561+00:00"}
{"study_id": 80771, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate melatonin's antidepressant-like effects, focusing on its role in circadian rhythm modulation and neuroplasticity in the hippocampus.", "results_summary": "The study found that melatonin enhances neurogenesis and neuronal differentiation, suggesting potential benefits for mood disorder patients by synchronizing circadian rhythms and improving neuroplasticity. It also highlighted melatonin receptor signaling pathways as key mediators of these effects.", "population_specificity": "Patients with mood disorders, particularly major depressive disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:36.783716+00:00"}
{"study_id": 80769, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to examine melatonin's potential to improve therapeutic outcomes in breast radiation therapy, particularly for estrogen receptor-positive patients.", "results_summary": "Melatonin pre-treatment was associated with decreased cell proliferation and increased p53 mRNA expression, enhancing radiosensitivity in breast cancer cells. It also reduced radiation-induced side effects in both breast cancer patients and rodent models.", "population_specificity": "Breast cancer patients (specifically estrogen receptor-positive) and rodent models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Interaction with estrogen regulation mentioned, but no specific medications, foods, or supplements noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:37.012853+00:00"}
{"study_id": 80773, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the anticancer role of melatonin by examining its effects on various cancer hallmarks.", "results_summary": "Melatonin demonstrates anticancer activity by interfering with multiple cancer hallmarks, including proliferation, metastasis, and immune evasion, suggesting its potential as a promising anticancer agent.", "population_specificity": "Not specified (review of existing studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:37.130680+00:00"}
{"study_id": 80768, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to examine whether detrimental TRYCATs, which increase in depression and cancer, are a pathophysiological link between the two diseases and whether IDO (indoleamine 2,3-dioxygenase) is a potential pharmacological target for treating comorbid depression and cancer.", "results_summary": "The abstract discusses the role of IDO in the TRYCAT pathway, linking inflammation in both depression and cancer, but does not provide specific results regarding Melatonin's effects.", "population_specificity": "Not specified (focus on inflammatory mechanisms in depression and cancer).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:37.413004+00:00"}
{"study_id": 80770, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to identify new therapeutic targets, including melatonin, for treating trigeminal autonomic cephalalgias (TACs).", "results_summary": "The abstract mentions melatonin as one of the neuropeptide and molecular targets under investigation for TACs, but no specific results regarding its effects are provided.", "population_specificity": "Patients with trigeminal autonomic cephalalgias (TACs).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:37.565419+00:00"}
{"study_id": 80772, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review melatonin's neuroprotective role and its involvement in the pathophysiology of neurological disorders such as stroke, Alzheimer's disease, and Parkinson's disease.", "results_summary": "The study found that melatonin has a wide-ranging regulatory and neuroprotective role, with potential therapeutic benefits for neurological disorders and no reported side effects. It also indicated disturbed melatonin levels in certain neurological conditions, suggesting its involvement in disease pathophysiology.", "population_specificity": "Patients with neurological conditions (stroke, Alzheimer's disease, Parkinson's disease)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:38.398567+00:00"}
{"study_id": 80775, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to analyze the neurobiological and clinical evidence of pharmacological treatments for insomnia, excluding benzodiazepines and Z-drugs, with a focus on melatonergic agonists like melatonin.", "results_summary": "The abstract does not provide specific results regarding melatonin's effects, as it is a review discussing multiple treatments without detailed findings.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not provided in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:39.333305+00:00"}
{"study_id": 80774, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to systematically review the pleiotropic roles of melatonin in endometriosis (EMS), recurrent spontaneous abortion (RSA), and polycystic ovary syndrome (PCOS) to explore its pathological implications and treatment potential.", "results_summary": "The study found that melatonin acts as a broad-spectrum antioxidant, anti-inflammatory agent, and immunoregulator, playing essential roles in EMS, RSA, and PCOS by regulating inflammation, immune function, and protecting cells or organs. It suggests melatonin as a candidate therapeutic drug for these conditions.", "population_specificity": "Female reproductive system disorders (EMS, RSA, PCOS)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:41.557216+00:00"}
{"study_id": 80776, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were not studying Melatonin; the abstract focuses on maternal thyroid hormones and glucocorticoids and their impact on fetal neurodevelopment.", "results_summary": "The abstract does not mention Melatonin or its effects.", "population_specificity": "Pregnant women and their offspring.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:43.285062+00:00"}
{"study_id": 80779, "supplement_id": 1328, "safety_score": "70", "efficacy_score": 65, "quality_score": 60, "study_goal": "The researchers aimed to assess the efficacy, safety, and tolerability of melatonin combined with an antidepressant compared to monotherapy or placebo for fibromyalgia pain relief.", "results_summary": "The study found some evidence that melatonin combined with amitriptyline reduced pain compared to monotherapy, but the evidence was limited and of very low quality. Adverse events were not serious and were common across all treatments.", "population_specificity": "Adults with fibromyalgia.", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:44.734989+00:00"}
{"study_id": 80777, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential anticancer effects of dietary supplements, including Melatonin, in the context of cancer prevention, recurrence reduction, and survival prolongation.", "results_summary": "The study suggests that Melatonin is one of the few complementary therapies that may have potential benefits, unlike most other supplements which lack sufficient safety and efficacy data. However, the role of specific interventions like Melatonin in advanced malignancies remains uncertain and debated.", "population_specificity": "General population and cancer survivors, with specific focus on patients with advanced malignancies.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:45.161228+00:00"}
{"study_id": 80780, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to synthesize melatonin's functional properties and explore its potential as a therapeutic candidate for dermatological conditions, skin cancer prevention, and environmental damage recovery.", "results_summary": "Melatonin exhibits antioxidative, DNA repair, immunomodulatory, thermoregulatory, and antitumor properties, making it promising for managing dermatoses, skin cancer prevention, and skin protection from environmental damage. Human skin and hair follicles express melatonin receptors and engage in extrapineal melatonin synthesis, suggesting therapeutic potential.", "population_specificity": "Not specified (general dermatological applications)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:45.218818+00:00"}
{"study_id": 80778, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review melatonin's anti-tumor activities, mechanisms of action, and clinical efficacy in breast cancer, particularly its potential benefits for high-risk women.", "results_summary": "Melatonin disrupts estrogen-dependent cell signaling, reduces estrogen-stimulated cells, and shows neuro-immunomodulatory effects. Observational and clinical studies link lower melatonin levels and circadian disruption to increased breast cancer risk, suggesting supplementation may benefit high-risk women.", "population_specificity": "Women, particularly those at high risk for breast cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:45.803825+00:00"}
{"study_id": 80782, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the current literature on melatonin's role in modulating autophagy and its potential therapeutic effects in neurodegenerative, cardiovascular, and endocrine disorders.", "results_summary": "Melatonin demonstrated significant protective effects in various in vitro and in vivo studies by modulating autophagy, either enhancing or inhibiting the process, suggesting promise for treating major diseases.", "population_specificity": "Nonclinical studies (in vitro and in vivo models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:46.249648+00:00"}
{"study_id": 80781, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the potential of melatonin as an adjuvant therapy for breast cancer prevention in high-risk individuals, focusing on its antiestrogenic and antioxidant properties.", "results_summary": "Melatonin may counteract BC risk factors such as night shift work, exposure to metalloestrogens, and obesity by reducing estrogenic effects, improving metabolic parameters, and enhancing the efficacy of conventional antiestrogens. However, clinical trials on this subject remain limited.", "population_specificity": "High-risk individuals for breast cancer, including night shift workers, those exposed to metalloestrogens like cadmium, and obese women.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:47.250459+00:00"}
{"study_id": 80783, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the evidence from systematic and narrative reviews on the effects of melatonin (both endogenous and exogenous) on health and identify potential mechanisms of action.", "results_summary": "The study found that melatonin was associated with a wide variety of health outcomes, with significant effects on sleep latency, pre-operative anxiety, agitation prevention, and breast cancer risk. However, most reviews were of low methodological quality, highlighting the need for more high-quality randomized clinical trials.", "population_specificity": "Clinically and methodologically heterogeneous populations (not specified further).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:49.403510+00:00"}
{"study_id": 80784, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review clinical trial evidence on pharmaceuticals, including melatonin, for treating co-occurring symptoms in autism spectrum disorder (ASD).", "results_summary": "The study found melatonin effective for treating sleep-related symptoms in children and youth with ASD, though no evidence supports its use for core ASD symptoms.", "population_specificity": "Children and youth with autism spectrum disorder (ASD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:50.105189+00:00"}
{"study_id": 80785, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore melatonin's role in cancer therapy, focusing on its ability to enhance chemo/radiotherapy efficacy and counteract drug resistance in malignant cells.", "results_summary": "Melatonin was found to improve cancer treatment response by modulating drug targets, reducing drug clearance, altering DNA repair mechanisms, and enhancing cell death pathways like apoptosis and autophagy. These effects were linked to melatonin's influence on key signaling pathways such as Akt and MAPK.", "population_specificity": "Cancer patients, specifically those with breast, lung, hepatic, colon cancers, and leukemia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:52.680315+00:00"}
{"study_id": 80788, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate melatonin's potential role in preventing ischemia-reperfusion injury and protecting against cardiomyocyte death in myocardial infarction.", "results_summary": "Melatonin demonstrated powerful antioxidative and anti-inflammatory properties, showing promise in reducing myocardial reperfusion injury and protecting cardiomyocytes. The study summarized existing research on melatonin's mechanisms and benefits in this context.", "population_specificity": "Patients with acute myocardial infarction (MI) undergoing reperfusion therapy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:53.250739+00:00"}
{"study_id": 80786, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to investigate the role of melatonin in alleviating excessive nighttime sleepiness and daytime insomnia in non-standard shift workers experiencing shift work sleep disorder (SWSD).", "results_summary": "The study found that melatonin, along with other interventions like planned naps and timed light exposure, has limited evidence to support its efficacy in treating SWSD symptoms. The associations between shift work and negative health outcomes were stronger in the presence of SWSD, but melatonin's effectiveness remains unclear.", "population_specificity": "Non-standard shift workers, particularly those with shift work sleep disorder (SWSD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:53.855185+00:00"}
{"study_id": 80787, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review melatonin's preparation, biological features, and clinical findings in cancer patients, focusing on its potential to inhibit tumor growth and improve treatment outcomes.", "results_summary": "Melatonin, alone or combined with chemo/radiotherapy, improved tumor regression and survival in advanced solid tumor patients, enhanced chemotherapy tolerance, and demonstrated antidegenerative, immunomodulatory, and oxidative stress-limiting effects. The MLT-DBM formulation showed positive therapeutic responses with no toxicity.", "population_specificity": "Cancer patients with advanced solid tumors.", "effective_dosage": "Melatonin with adenosine at a 1:4 ratio, stabilized with 30% glycine (MLT-DBM).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:53.951938+00:00"}
{"study_id": 80789, "supplement_id": 1328, "safety_score": "70", "efficacy_score": 30, "quality_score": 80, "study_goal": "The researchers aimed to assess whether melatonin (5 mg) as an adjuvant treatment improves anxiety, depression, stress, and sleep complaints in males recovering from substance use.", "results_summary": "The study found no statistically significant differences between melatonin and placebo for any measured outcomes, though adverse events were more frequent in the melatonin group. The diversity of medication regimens and treatment services complicated efficacy assessment.", "population_specificity": "Males aged 18+ in recovery from substance use at a residential program in south-western Pennsylvania.", "effective_dosage": "5 mg melatonin daily.", "study_duration": "28 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:54.354493+00:00"}
{"study_id": 80790, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 85, "quality_score": 88, "study_goal": "The researchers aimed to determine the efficacy of melatonin supplementation for improving sleep disturbances in patients with traumatic brain injury (TBI).", "results_summary": "Melatonin significantly improved subjective sleep quality and some objective measures (sleep efficiency, vitality, mental health) while reducing anxiety and fatigue, but had no effect on sleep onset latency or daytime sleepiness. No serious adverse events were reported.", "population_specificity": "Outpatients with mild to severe TBI experiencing sleep disturbances (mean age 37 years, 67% men).", "effective_dosage": "2 mg prolonged-release melatonin (Circadin\u00ae) nightly, 2 hours before bedtime.", "study_duration": "4 weeks per treatment (melatonin and placebo), with a 48-hour washout period.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:55.980496+00:00"}
{"study_id": 80791, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of pharmaceutical adjuvants, including melatonin, in assisting with benzodiazepine tapering and discontinuation in a geriatric population.", "results_summary": "The study found that the use of pharmaceutical adjuvants, including melatonin, for benzodiazepine tapering was inconclusive, with no clear evidence of efficacy.", "population_specificity": "Primarily geriatric population with long-term benzodiazepine use.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:57.202853+00:00"}
{"study_id": 80792, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to explore the role of melatonin in circadian rhythm regulation and its therapeutic potential for disorders like sleep disturbances, nocturnal hypertension, and Alzheimer's disease.", "results_summary": "Melatonin demonstrated clinically meaningful effects in circadian rhythm-related sleep disorders, jet lag, shift work, and insomnia in children with neurodevelopmental disorders. It also showed promise in improving sleep quality and addressing non-dipping nocturnal blood pressure, with emerging evidence linking it to early intervention in Alzheimer's disease.", "population_specificity": "Humans, including individuals with circadian rhythm disorders, neurodevelopmental disorders, nocturnal hypertension, and Alzheimer's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:58.242693+00:00"}
{"study_id": 80793, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review melatonin's protective mechanisms against muscle injury caused by trauma or strenuous exercise.", "results_summary": "Melatonin demonstrated potent antioxidant and anti-inflammatory effects, inhibiting NF\u03baB, reducing cytokine expression, and increasing Akt activity, which may protect against muscle injury. However, the exact mechanisms remain multifactorial and not fully described.", "population_specificity": "Athletes and individuals with muscle injuries from trauma or strenuous exercise.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:33:59.413863+00:00"}
{"study_id": 80795, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 30, "study_goal": "The researchers aimed to present provocative, unproven ideas to stimulate new thinking and dialogue about bedside management, rather than specifically studying Melatonin.", "results_summary": "The abstract does not present specific findings about Melatonin, focusing instead on broader clinical science challenges and unproven ideas.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:00.357792+00:00"}
{"study_id": 80794, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 30, "quality_score": 60, "study_goal": "The researchers aimed to review the role of alterations in tryptophan metabolism, including the serotonin and melatonin pathways, in postpartum depression (PPD).", "results_summary": "The study found that PPD is associated with decreased serotonin and melatonin due to stress hormones and immune-inflammatory activity diverting tryptophan metabolism toward the kynurenine pathway, which may contribute to depressive symptoms.", "population_specificity": "New mothers with postpartum depression.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:00.770193+00:00"}
{"study_id": 80796, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of melatonin, in combination with D-beta-hydroxybutyrate (BHB/M), as a hibernation-based treatment for hemorrhagic shock.", "results_summary": "The study suggests that melatonin, combined with BHB, may help alleviate the detrimental effects of hemorrhagic shock by mimicking protective mechanisms observed in hibernators. However, specific efficacy data for melatonin alone are not detailed in the abstract.", "population_specificity": "Preclinical and clinical approaches for hemorrhagic shock treatment (specific population not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:01.826061+00:00"}
{"study_id": 80797, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review the morphoquantitative, histological, and pathological effects of Diclofenac sodium (DS) on the central and peripheral nervous systems.", "results_summary": "The abstract describes DS-induced cytotoxicity in the nervous system, prenatal toxicities potentially leading to postnatal defects, and suggests the need for understanding DS-dependent neuronal impairments to guide antioxidant therapy.", "population_specificity": "Not specified (review of existing studies).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:02.840221+00:00"}
{"study_id": 80799, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore melatonin's physiological roles beyond circadian rhythm regulation.", "results_summary": "The abstract mentions melatonin's actions via two main receptor types but does not provide specific findings on its effects.", "population_specificity": "Not specified", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:03.178189+00:00"}
{"study_id": 80798, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to evaluate the effects of melatonin administration on metabolic status in diabetic patients with coronary heart disease (CHD).", "results_summary": "Melatonin supplementation significantly improved oxidative stress markers (GSH, NO, MDA, PCO), reduced inflammation (hs-CRP), enhanced glycemic control, improved lipid profiles, and lowered blood pressure compared to placebo.", "population_specificity": "Diabetic patients with coronary heart disease (n=60).", "effective_dosage": "10 mg melatonin (2 capsules of 5 mg each) once daily.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:03.759174+00:00"}
{"study_id": 80800, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the impact of blue light exposure on melatonin secretion and its potential effects on sleep, alertness, and circadian rhythms in mental illness.", "results_summary": "Blue light exposure was found to suppress melatonin, increase alertness, and interfere with sleep in young, healthy volunteers and animals, raising concerns about its effects on mental illness-related circadian symptoms.", "population_specificity": "Young, healthy volunteers and animals; potential implications for individuals with mental illness.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:05.766280+00:00"}
{"study_id": 80801, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of melatonin for treating sleep problems in children with autism spectrum disorder.", "results_summary": "The study found that melatonin may be useful for treating sleep problems in children with autism spectrum disorder, though the evidence for medication use in adults is limited and largely based on extrapolations from studies in children.", "population_specificity": "Children with autism spectrum disorder", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:06.362293+00:00"}
{"study_id": 80802, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine Melatonin's role as a circadian signal and its efficacy in treating circadian rhythm disorders.", "results_summary": "The study confirmed Melatonin's efficacy in circadian rhythm disorders and highlighted its role as an endogenous synchronizer within the circadian system. It also noted the presence of MT1 and MT2 receptor subtypes with distinct distribution patterns.", "population_specificity": "Humans (specific population not detailed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:07.612257+00:00"}
{"study_id": 80803, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate melatonin's role in preventing and treating cancer, focusing on its antioxidant properties and impact on tumor growth.", "results_summary": "Melatonin demonstrated potential in suppressing tumor growth in vivo and in vitro, with notable antioxidant activity that may limit or reverse cancer-related changes.", "population_specificity": "Not specified (in vivo and in vitro studies referenced).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:07.990882+00:00"}
{"study_id": 80804, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of melatonin in facilitating sleep schedule changes and enhancing sports performance in athletes.", "results_summary": "The study found that melatonin, along with caffeine and nonbenzodiazepine sleep aids, can help athletes adjust their sleep schedules and improve performance. However, data specific to athletes is limited, and conclusions were partly drawn from studies on shift workers and airline personnel.", "population_specificity": "Athletes, with supplementary evidence from shift workers and airline personnel.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:09.387435+00:00"}
{"study_id": 80805, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of melatonin in the treatment of rapid eye movement sleep behavior disorder (RBD), including its efficacy and potential as part of pharmacological interventions.", "results_summary": "The study mentions melatonin as one of the pharmacological treatments for RBD, alongside clonazepam, but does not provide specific efficacy data or comparative outcomes for melatonin alone.", "population_specificity": "Adults with rapid eye movement sleep behavior disorder (RBD), including those with neurodegenerative disorders like Parkinson's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:10.974881+00:00"}
{"study_id": 80806, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the clinical and radiographic outcomes of using autogenous bone graft (ABG) combined with melatonin versus ABG alone around immediate dental implants in the esthetic zone.", "results_summary": "The ABG/melatonin group showed significantly less marginal bone loss, higher bone density, improved gingival index, reduced peri-implant sulcus depth, and better wound healing scores compared to the ABG-only group.", "population_specificity": "26 patients with nonrestorable anterior/premolar teeth.", "effective_dosage": "Not specified", "study_duration": "9 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:11.419307+00:00"}
{"study_id": 80807, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the effects of melatonin on protozoan parasite biology and the host's immune response in various infections.", "results_summary": "Melatonin enhances the host's immune response in toxoplasmosis, African trypanosomiasis, and Chagas' disease by regulating inflammatory mediators. In amoebiasis, it reduces lesions and increases leukophagocytosis, while in giardiasis, elevated melatonin levels correlate with phagocytic activity. In leishmaniasis, melatonin arrests parasite replication.", "population_specificity": "Vertebrates (general, no specific human or animal subgroup detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:11.901420+00:00"}
{"study_id": 80808, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review therapeutics, including melatonin, that target aging and oxidative stress in the context of COPD therapy.", "results_summary": "The abstract does not provide specific findings about melatonin's effects, only mentioning it as one of several potential therapeutics for COPD.", "population_specificity": "Patients with chronic obstructive pulmonary disease (COPD).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:12.302455+00:00"}
{"study_id": 80809, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to review evidence on the prevention and management of postoperative sleep disturbances, including the role of melatonin.", "results_summary": "The study found that melatonin, among other pharmacological measures, can be used to improve postoperative sleep, potentially enhancing recovery outcomes, though long-term effects require further study.", "population_specificity": "Postoperative patients with sleep disturbances.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:13.241468+00:00"}
{"study_id": 80810, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the interaction between melatonin's chronobiotic role and its immune defense functions, focusing on the immune-pineal axis.", "results_summary": "The study found that melatonin synthesis shifts from the pineal gland to immune cells during acute inflammation and back upon resolution, highlighting its systemic role in immune regulation. The immune-pineal axis's dysregulation may have pathophysiological relevance in conditions like neurodegenerative diseases and cancer.", "population_specificity": "Not specified (review of existing literature)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:15.061031+00:00"}
{"study_id": 80811, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the role of melatonin in reducing injury potential in patients with rapid eye movement sleep behavior disorder (RBD).", "results_summary": "The study found that melatonin (3 to 12 mg) is a recommended treatment for RBD to reduce injury risk, alongside clonazepam, though long-term outcomes and neuroprotective effects require further study.", "population_specificity": "Patients with rapid eye movement sleep behavior disorder (RBD), particularly those at risk of neurodegenerative diseases like Parkinson's disease and dementia with Lewy bodies.", "effective_dosage": "3 to 12 mg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:16.341144+00:00"}
{"study_id": 80812, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine if wearing amber-tinted blue light-blocking lenses before bedtime improves sleep in individuals with insomnia by mitigating melatonin suppression and neurophysiologic arousal.", "results_summary": "The study found that wearing amber lenses significantly improved sleep quality, total sleep time, and reduced insomnia symptoms compared to clear placebo lenses, as measured by subjective and actigraphic assessments.", "population_specificity": "Fourteen individuals (8 females, mean age 46.6 \u00b1 11.5 years) with insomnia symptoms.", "effective_dosage": "Not applicable (intervention was lens use, not melatonin supplementation).", "study_duration": "7 consecutive nights per intervention period, with a 4-week washout.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:17.881319+00:00"}
{"study_id": 80815, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the potential of melatonin as an antioxidant therapy for pulmonary hypertension (PH) by examining its effects on oxidative stress, vasodilation, fibrosis, and right ventricular hypertrophy.", "results_summary": "Melatonin was found to enhance antioxidant capacity, improve vasodilation, counteract lung and cardiac fibrosis, and reduce right ventricular hypertrophy/failure in PH models. The study suggests melatonin is a safe, cost-effective, and promising therapeutic option for PH.", "population_specificity": "Pulmonary hypertension (PH) patients and animal models of PH.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:20.059906+00:00"}
{"study_id": 80814, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to clarify the controversial role of the MTNR1B gene (encoding a melatonin receptor) in the pathophysiology of type 2 diabetes (T2D).", "results_summary": "The study highlights strong controversies in interpreting the role of MTNR1B in T2D, with conflicting findings from genetic, clinical, functional, and animal model analyses. The authors discuss potential caveats and suggest ways to improve understanding of T2D mechanisms, noting melatonin's versatile regulatory functions.", "population_specificity": "General focus on genetic and pathophysiological aspects of type 2 diabetes, not a specific clinical population.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:20.336234+00:00"}
{"study_id": 80817, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the molecular anti-angiogenesis pathways mediated by melatonin and its mechanisms in various cancers.", "results_summary": "Melatonin inhibits angiogenesis by targeting HIF-1\u03b1 and VEGF, preventing endothelial cell migration, invasion, and tube formation, thereby exerting anti-tumor effects.", "population_specificity": "Various types of cancers (in vitro and in vivo studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:20.380807+00:00"}
{"study_id": 80813, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 90, "quality_score": 92, "study_goal": "To assess the efficacy and safety of prolonged-release melatonin minitablets (PedPRM) versus placebo for treating insomnia in children and adolescents with autism spectrum disorder (ASD) and neurogenetic disorders (NGD).", "results_summary": "PedPRM significantly increased total sleep time by 57.5 minutes compared to 9.14 minutes with placebo and reduced sleep latency by 39.6 minutes versus 12.5 minutes with placebo. The treatment was generally safe, with somnolence being the most commonly reported adverse effect.", "population_specificity": "Children and adolescents (2-17.5 years) with ASD (96.8%) or Smith-Magenis syndrome (3.2%) who had unimproved sleep despite behavioral interventions.", "effective_dosage": "2 mg escalated to 5 mg.", "study_duration": "13 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:20.382114+00:00"}
{"study_id": 80816, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 30, "quality_score": 75, "study_goal": "The researchers aimed to determine whether melatonin administration during acute myocardial reperfusion improves the myocardial salvage index in patients with ST-elevation myocardial infarction.", "results_summary": "Melatonin did not improve the myocardial salvage index compared to placebo, and biomarker levels and clinical event frequencies were similar between groups. The study concluded that melatonin had no significant benefit in this context.", "population_specificity": "Patients with ST-elevation myocardial infarction (n=48).", "effective_dosage": "Total 50 mg (intracoronary and intravenous).", "study_duration": "Administered during acute myocardial reperfusion, with outcomes assessed at day 4 (\u00b11 day).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:20.581805+00:00"}
{"study_id": 80818, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to describe melatonin's neuroregulatory and neuroprotective properties and its signaling mechanisms via GPCRs.", "results_summary": "The abstract highlights melatonin's diverse neuroregulatory and neuroprotective effects but does not provide specific study results.", "population_specificity": "Not specified", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:21.612278+00:00"}
{"study_id": 80819, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of circadian function in Parkinson's disease, including potential mechanisms and therapeutic benefits of manipulating the circadian system.", "results_summary": "The review highlights preclinical studies suggesting circadian involvement in Parkinson's disease and discusses possible mechanisms, but does not provide specific findings on Melatonin's effects.", "population_specificity": "Not specified (focus on preclinical and clinical studies broadly related to Parkinson's disease).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:23.345267+00:00"}
{"study_id": 80820, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the safety and efficacy of melatonin as a treatment for sleep disturbances in children with neurodevelopmental disabilities (NDDs).", "results_summary": "The study found that melatonin is considered the safest choice for children with NDDs, supported by an increasing body of evidence, though well-controlled studies with objective measures are still needed.", "population_specificity": "Children with neurodevelopmental disabilities (NDDs) experiencing sleep disturbances.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:25.155164+00:00"}
{"study_id": 80823, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to synthesize literature on chronobiological theories of mood disorders and explore the potential of melatonin agonists as a complementary treatment for major depressive disorder (MDD).", "results_summary": "The study found that melatonin agonists could complement MDD treatment by addressing sleep disturbances and circadian rhythm dysfunctions, though the direction of causality remains unclear. Current antidepressants do not effectively treat these chronobiological disturbances.", "population_specificity": "Adults with major depressive disorder (MDD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:28.023700+00:00"}
{"study_id": 80824, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to explore melatonin's mechanisms of action and therapeutic potential in haematological neoplasms, including its pro-apoptotic, pro-oxidative, anti-proliferative, and immunomodulatory effects.", "results_summary": "Melatonin demonstrated low-toxicity protective effects against experimental haematological neoplasms, with potential benefits in combination therapies, though some findings contradicted its suppressive effects on these cancers.", "population_specificity": "Not specified (focus on experimental haematological neoplasms).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:28.360136+00:00"}
{"study_id": 80826, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to analyze the effects of common treatments for insomnia and OSA, including melatonin, on sleep and glucose metabolism in patients with type 2 diabetes.", "results_summary": "The abstract does not provide specific findings about melatonin's effects, only mentioning it as one of the treatments analyzed.", "population_specificity": "Patients with type 2 diabetes who have insomnia or obstructive sleep apnoea (OSA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:28.705465+00:00"}
{"study_id": 80825, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine if melatonin could reduce the metabolic effects of second-generation antipsychotics in patients.", "results_summary": "Melatonin significantly increased HDL levels and decreased fasting blood sugar and systolic blood pressure, but also increased waist circumference, weight, and BMI compared to placebo. The study concluded that melatonin could mitigate some metabolic effects of atypical antipsychotics.", "population_specificity": "100 patients aged 18-64 years old, newly treated with second-generation antipsychotics.", "effective_dosage": "3mg slow-release melatonin, administered at 8 p.m.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:28.809869+00:00"}
{"study_id": 80821, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore melatonin's potential role in the pathogenesis and treatment of periodontitis, particularly when comorbid with other systemic conditions.", "results_summary": "The abstract suggests melatonin has anti-inflammatory and antioxidant properties that may benefit periodontal tissue homeostasis and treatment of periodontitis, especially in comorbid conditions like diabetes and Alzheimer's disease.", "population_specificity": "Patients with periodontal disease, potentially comorbid with systemic conditions such as diabetes, metabolic syndrome, depression, or Alzheimer's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:29.221400+00:00"}
{"study_id": 80827, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness and safety of melatonin for cognitive enhancement in Army personnel.", "results_summary": "Melatonin showed mixed results, with improvements and no effects compared to placebo on two cognitive outcomes. Safety outcomes, such as adverse events, were rarely reported.", "population_specificity": "Australian Army personnel", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:29.618438+00:00"}
{"study_id": 80822, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the effectiveness of melatonin as a treatment option for REM sleep behaviour disorder (RBD).", "results_summary": "The study found that melatonin is an effective pharmacotherapy option for RBD, alongside clonazepam, and is used in treating underlying causes and modifying the sleep environment. It also highlighted that idiopathic RBD may represent a prodromal phase of Parkinson disease or dementia with Lewy bodies.", "population_specificity": "Older population, particularly those with idiopathic or secondary RBD, including patients with neurodegenerative conditions, antidepressant use, obstructive sleep apnoea, or narcolepsy.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:30.335420+00:00"}
{"study_id": 80828, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy and tolerability of agomelatine (a melatonergic drug) compared to fluoxetine in treating major depressive disorder with severe depression, and their effects on serum BDNF and TNF-\u03b1 levels.", "results_summary": "Both agomelatine and fluoxetine significantly reduced HAM-D scores, increased BDNF levels, and decreased TNF-\u03b1 levels over 12 weeks, with agomelatine showing a greater reduction in TNF-\u03b1. Both treatments were safe and well-tolerated.", "population_specificity": "Patients with major depressive disorder and severe depression (HAM-D score \u226525).", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:34.573408+00:00"}
{"study_id": 80829, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review melatonin's cytoprotective and anti-inflammatory effects in metabolic syndrome (MS) and its potential therapeutic value.", "results_summary": "Melatonin was found to improve sleep efficiency, exhibit antioxidant and anti-inflammatory properties, and act as a metabolic regulator and mitochondrial protector, potentially attenuating inflammatory responses in MS. Clinical data support its therapeutic potential for human MS.", "population_specificity": "Individuals with metabolic syndrome or conditions associated with insulin resistance.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:35.808285+00:00"}
{"study_id": 80830, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to compare the therapeutic effect of melatonin versus sodium valproate in the prophylaxis of chronic migraine.", "results_summary": "Melatonin significantly reduced migraine attack frequency, duration, severity, and MIDAS scores, with efficacy comparable to sodium valproate but with fewer adverse events. The placebo group showed no significant improvements.", "population_specificity": "Patients with chronic migraine receiving baseline therapy with nortriptyline and propranolol.", "effective_dosage": "3 mg melatonin daily.", "study_duration": "2 months.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:36.137261+00:00"}
{"study_id": 80832, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 70, "study_goal": "The researchers aimed to identify and describe compounds, including Melatonin, in clinical development for epilepsy treatment in 2016.", "results_summary": "Melatonin was listed among compounds initially developed for other diseases but considered for epilepsy treatment. The abstract does not provide specific efficacy results for Melatonin, only noting that most compounds had mechanisms similar to existing anti-seizure drugs.", "population_specificity": "Patients with drug-resistant epilepsies (general mention, no specific subgroup for Melatonin).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:36.622615+00:00"}
{"study_id": 80831, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review the role of tryptophan (Trp) in serotonin and melatonin synthesis and its implications for treating sleep disorders, depression, and other conditions.", "results_summary": "The study highlights Trp's importance in serotonin and melatonin pathways, suggesting its potential efficacy in treating sleep disorders, depression, cognitive disorders, and neurodegenerative diseases. However, it does not provide specific clinical trial results on melatonin's effects.", "population_specificity": "General human population, with mentions of conditions like autism spectrum disorder, obesity, and eating disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:36.724606+00:00"}
{"study_id": 80834, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore melatonin's role in regulating mitochondrial physiology in the cardiovascular system, particularly its antioxidant potential and impact on the renin-angiotensin system.", "results_summary": "The study found that melatonin regulates blood pressure through central and peripheral mechanisms, improves mitochondrial function, and reduces reactive oxygen species production, supporting its therapeutic potential for cardiovascular health.", "population_specificity": "Not specified (general cardiovascular system focus).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:37.082937+00:00"}
{"study_id": 80833, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review melatonin's protective mechanisms against ischemia/reperfusion (IR) injury, focusing on mitochondrial dysfunction and its effects in various organs.", "results_summary": "Melatonin demonstrated strong protective effects against IR injury by targeting mitochondrial dysfunction, with evidence supporting its efficacy in brain, heart, liver, and other tissues. The review highlights melatonin's potential as a therapeutic agent but calls for further research.", "population_specificity": "Not specified (review of existing research, not a clinical trial)", "effective_dosage": "Not available", "study_duration": "Not applicable (review study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:37.478884+00:00"}
{"study_id": 80835, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review melatonin's mechanisms in protecting mitochondria and its potential as a therapeutic strategy against neurodegenerative disorders.", "results_summary": "Melatonin exhibits potent antioxidant properties and mitochondrial protection, which may prevent neurodegeneration progression, particularly in early disease stages. The study highlights melatonin's neuroprotective roles in conditions like Alzheimer's, Parkinson's, and Huntington's diseases.", "population_specificity": "Neurodegenerative disease models (e.g., Alzheimer's, Parkinson's, Huntington's)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:38.161591+00:00"}
{"study_id": 80836, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the connection between clock genes, innate immunity, and mitochondria in health and sepsis, and the role of melatonin in maintaining clock homeostasis.", "results_summary": "The study found that melatonin administration helps recover disrupted clock genes, normalizes innate immunity, and restores mitochondrial homeostasis, breaking the vicious cycle of inflammation and bioenergetic decay in sepsis.", "population_specificity": "Not specified (focus on experimental and clinical data related to sepsis and immune response).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:42.081997+00:00"}
{"study_id": 80837, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether melatonin can modulate mitochondrial functions in cancer cells, particularly its effects on the mitochondrial respiratory chain and glycolytic bioenergetic pathways.", "results_summary": "Melatonin was found to modulate the mitochondrial respiratory chain, potentially counteracting the highly glycolytic bioenergetic pathway of cancer cells. The study suggests melatonin may have a role in targeting mitochondrial dysfunction in cancer.", "population_specificity": "Cancer cells (in vitro or animal models implied, not explicitly stated).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:43.815991+00:00"}
{"study_id": 80838, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the rationale and utility of pharmacologic interventions, including melatonin receptor agonists, for treating insomnia in a multidisciplinary approach.", "results_summary": "The study highlights melatonin receptor agonists as one of the FDA-approved medications for insomnia, suggesting their utility in customized therapy for specific insomnia phenotypes. It emphasizes the importance of addressing underlying comorbidities in insomnia treatment.", "population_specificity": "Patients with insomnia, particularly those with underlying neurologic conditions, psychiatric conditions, or medical problems.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:44.029531+00:00"}
{"study_id": 80839, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of melatonin in circadian rhythms, its relationship to neurologic disorders, and the treatment of circadian rhythm sleep-wake disorders.", "results_summary": "The study highlights melatonin's role in circadian rhythms and its potential in treating sleep-wake disorders, such as advanced or delayed sleep-wake phase disorders, but does not provide specific efficacy data.", "population_specificity": "General discussion, with specific mention of elderly individuals for advanced sleep-wake phase disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:44.759870+00:00"}
{"study_id": 80840, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the current understanding of autophagy in cancer and explore melatonin's role in regulating programmed cell death.", "results_summary": "The abstract suggests melatonin may influence cancer cell death by regulating programmed cell death, but it does not provide specific data on its efficacy. The study highlights autophagy's dual role in cancer cell survival or death, depending on context.", "population_specificity": "Human cancer cell lines (not specified further).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:45.075498+00:00"}
{"study_id": 80842, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to compare salivary melatonin levels between HIV-positive patients and healthy controls to assess melatonin's potential role in HIV pathogenesis.", "results_summary": "Salivary melatonin levels were significantly lower in HIV-positive patients compared to healthy controls, suggesting a possible link between melatonin deficiency and HIV-related oxidative stress. No significant differences were found in smoking or addiction between groups, but gender differences were observed.", "population_specificity": "49 HIV-positive patients and 49 healthy subjects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:45.139532+00:00"}
{"study_id": 80843, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the therapeutic effects of melatonin on gastric cancer, focusing on its mechanisms and potential benefits in cancer pathogenesis and treatment.", "results_summary": "Melatonin demonstrated inhibitory effects on gastric cancer cells, impacting tumor growth, angiogenesis, metastasis, and anti-tumor immunity. It also reduced side effects of conventional therapies, though further research is needed to fully understand its mechanisms.", "population_specificity": "Various models (not specified if human, animal, or in vitro) related to gastric cancer.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:46.850660+00:00"}
{"study_id": 80841, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to compare the effects of melatonin and caloric restriction on the expression of Sirt1, FoxO1, FoxO3a, and FOXOs target genes in the aging mouse hippocampus, and to determine if NPY mediates melatonin's effects.", "results_summary": "Melatonin upregulated mRNA expression of Sirt1, FoxO1, FoxO3a, and target genes (p27, Wnt1, Wisp1) in aged mouse hippocampus, similar to caloric restriction. However, combining melatonin with caloric restriction did not produce additive effects, suggesting shared pathways. NPY was required for melatonin to mediate these gene expression effects.", "population_specificity": "19-month-old male mice (wild-type and NPY-knockout)", "effective_dosage": "10 mg/kg, daily, subcutaneously", "study_duration": "7 consecutive days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:47.338621+00:00"}
{"study_id": 80844, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the impact of melatonin treatment on human aggression, specifically reactive aggression, in healthy male volunteers.", "results_summary": "Participants who ingested melatonin selected high punishments more often than those who ingested placebo, indicating increased reactive aggression. This effect persisted after controlling for various psychological and physiological factors.", "population_specificity": "63 healthy male volunteers", "effective_dosage": "Not specified", "study_duration": "Single administration", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:49.438239+00:00"}
{"study_id": 80849, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the effects of melatonin, focusing on those dependent on the activation of mammalian MT receptors.", "results_summary": "The abstract does not provide specific findings on melatonin's effects, only mentioning its binding affinity to melatonin receptors and its multiple attributed effects.", "population_specificity": "Not specified", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:51.584489+00:00"}
{"study_id": 80845, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the role of melatonin and melatonergic pathways in breast milk and their implications for infant gut-brain axis development and immune system regulation.", "results_summary": "The study highlights that melatonin in breast milk influences gut-brain axis development and immune function, with potential links to reducing depression susceptibility. It suggests that melatonergic pathways are crucial for gut microbiome health and may prevent various medical conditions.", "population_specificity": "Infants, with broader implications for child and adult health.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:51.839142+00:00"}
{"study_id": 80846, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to review the molecular mechanisms of melatonin's antidiabetic and anticancer effects and explore its potential as a therapeutic agent for type 2 diabetes and cancer.", "results_summary": "Melatonin demonstrated antidiabetic benefits by reducing hyperglycemia, insulin resistance, oxidative stress, and inflammation, and exhibited multi-targeted anticancer effects by modulating cell survival, proliferation, and apoptosis pathways. It also showed synergistic benefits with chemotherapy and radiotherapy without adverse clinical outcomes.", "population_specificity": "General human health, particularly type 2 diabetes and cancer patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:52.115080+00:00"}
{"study_id": 80848, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the characteristics of non-SSRI new-generation antidepressants, including melatonin and serotonin agonists (MaSA), focusing on their pharmacodynamics, pharmacokinetics, and therapeutic drug monitoring.", "results_summary": "The abstract does not provide specific findings about Melatonin's effects, as it primarily reviews the broader category of new-generation antidepressants, including their mechanisms, pharmacokinetics, and analytical methods for monitoring.", "population_specificity": "Not specified (general review of antidepressants)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:52.781670+00:00"}
{"study_id": 80847, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review clinical trial results on melatonin's therapeutic potential for neurological diseases and mental disorders.", "results_summary": "The abstract highlights melatonin's diverse properties (e.g., antioxidant, anti-inflammatory) and its potential benefits in neurological and mental disorders, though translating lab results to clinical settings remains inconsistent. Clinical trials with robust methodologies are needed to confirm its efficacy.", "population_specificity": "Patients with neurological diseases (e.g., Alzheimer's, Parkinson's) and mental/behavioral disorders (e.g., autism spectrum disorders, ADHD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:53.476125+00:00"}
{"study_id": 80851, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to evaluate the potential of melatonin, among other supplements, to reduce the impact of sports-related concussions in athletes.", "results_summary": "The abstract mentions that current human trials for melatonin may soon provide more evidence for its use in reducing the impact of sports-related concussions, but no specific results are reported.", "population_specificity": "Athletes with sports-related concussions (human trials mentioned, but no specific details provided).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:55.198189+00:00"}
{"study_id": 80852, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of yellow (blue-blocking) and clear (UV-blocking) intraocular lenses on sleep and mood in aged patients undergoing cataract surgery, indirectly assessing melatonin-related outcomes.", "results_summary": "The study found no significant differences in sleep parameters between yellow and clear IOL groups, but a higher rate of mood deterioration (measured by BDI scores) was observed in the yellow IOL group.", "population_specificity": "Aged patients (mean age 76.2 \u00b1 7.5 years) undergoing bilateral cataract surgery.", "effective_dosage": "Not mentioned", "study_duration": "Assessments were made one week before and eight weeks after the last surgical procedure.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:58.049194+00:00"}
{"study_id": 80853, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of melatonin and circadian disruption in obesity and breast cancer, focusing on epigenetic modifications like DNA methylation.", "results_summary": "The study suggests melatonin and circadian clock genes play a role in obesity and breast cancer development, with DNA methylation as a key epigenetic mechanism influenced by artificial light-at-night (ALAN). Melatonin suppression and DNA methylation patterns may serve as biomarkers for early detection.", "population_specificity": "General discussion, no specific population studied.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:34:59.182147+00:00"}
{"study_id": 80854, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of controlled-release melatonin as a first-line treatment for insomnia in older adults and the general population.", "results_summary": "Controlled-release melatonin is recommended as a first-line agent for insomnia in older adults and for those with difficulty falling asleep in the general population. It is considered safe and effective compared to other pharmacologic options.", "population_specificity": "Older adults and the general population with insomnia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:00.525211+00:00"}
{"study_id": 80855, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy and safety of sublingual ramelteon (a melatonin receptor agonist) as adjunctive maintenance therapy for bipolar I disorder.", "results_summary": "The study found no significant differences between any dose of ramelteon SL and placebo in preventing relapse of symptoms. Ramelteon SL was well tolerated, with a safety profile consistent with oral ramelteon.", "population_specificity": "Adult bipolar I disorder patients stable for \u2265 8 weeks before baseline, with a mood episode 8 weeks to 9 months before screening.", "effective_dosage": "0.1mg, 0.4mg, and 0.8mg once daily.", "study_duration": "Not specified (terminated after interim futility analysis).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:01.587498+00:00"}
{"study_id": 80856, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to analyze the therapeutic potential of melatonin in age-related ocular diseases by examining its effects on nitro-oxidative stress, autophagy, inflammation, and angiogenesis mechanisms.", "results_summary": "The study found that melatonin exhibits antioxidant, anti-inflammatory, anti-angiogenic, and autophagy-modulating properties, making it a promising therapeutic agent for age-related ocular diseases such as cataract, glaucoma, age-related macular degeneration, and diabetic retinopathy.", "population_specificity": "Individuals with age-related ocular diseases (e.g., cataract, glaucoma, age-related macular degeneration, diabetic retinopathy).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:02.556530+00:00"}
{"study_id": 80858, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to assess the evidence base for the therapeutic effects of exogenous melatonin in treating primary sleep disorders.", "results_summary": "The meta-analysis found convincing evidence that exogenous melatonin reduces sleep onset latency in primary insomnia and delayed sleep phase syndrome, and regulates sleep-wake patterns in blind patients compared to placebo. The results highlight melatonin's potential importance in treating certain sleep disorders.", "population_specificity": "Patients with primary insomnia, delayed sleep phase syndrome, non 24-h sleep-wake syndrome in blind individuals, and rapid eye movement-behaviour disorder.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:03.321675+00:00"}
{"study_id": 80857, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if adjuvant melatonin could minimize oral mucositis complications and reduce treatment delays in head and neck cancer patients undergoing concurrent chemoradiation.", "results_summary": "Melatonin delayed the onset of grade 3 mucositis, reduced morphine consumption, and allowed more uninterrupted treatment sessions, though it did not significantly lower the incidence of mucositis or xerostomia. Quality of life remained comparable between groups.", "population_specificity": "Head and neck cancer patients receiving concurrent chemoradiation (5 days/week of radiation plus chemotherapy three or six cycles).", "effective_dosage": "20 mg melatonin gargle before each irradiation and 20 mg melatonin capsules nightly.", "study_duration": "7 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:03.588947+00:00"}
{"study_id": 80850, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the role of melatonin in modulating oxidative stress and its potential as a preventive and adjuvant therapy for breast cancer.", "results_summary": "The study suggests melatonin plays a significant role in breast cancer prevention and adjuvant therapy by modulating oxidative stress and reactive oxygen species (ROS) levels, aligning with existing literature.", "population_specificity": "Breast cancer cells (in vitro or animal models, not explicitly specified for human trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:04.051694+00:00"}
{"study_id": 80861, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to assess whether melatonin could counteract adverse hepatic effects caused by statins.", "results_summary": "The abstract does not provide specific results regarding melatonin's effectiveness in mitigating statin-induced liver enzyme elevation.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:05.662650+00:00"}
{"study_id": 80859, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether the timing of melatonin administration influences its treatment effect in reducing infarct size in STEMI patients undergoing pPCI.", "results_summary": "Melatonin significantly reduced infarct size in patients treated early (first tertile) but was associated with larger infarct size in those treated later (third tertile), showing a significant interaction based on timing.", "population_specificity": "146 patients with STEMI presenting within 360 minutes of chest pain onset.", "effective_dosage": "Intravenous and intracoronary bolus (specific amounts not detailed).", "study_duration": "Administered during pPCI (single intervention).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:06.795917+00:00"}
{"study_id": 80862, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to explore the role of melatonin in autoimmune diseases, particularly its seasonal variation and immunomodulatory effects on conditions like multiple sclerosis and systemic lupus erythematosus.", "results_summary": "Melatonin was found to ameliorate the severity of several autoimmune diseases, with its lowest levels in spring correlating with higher exacerbation rates of multiple sclerosis. It also influences adhesion molecule and transcription factor expression, potentially affecting inflammatory bowel diseases.", "population_specificity": "Patients with autoimmune diseases (e.g., multiple sclerosis, systemic lupus erythematosus, inflammatory bowel diseases).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:09.816133+00:00"}
{"study_id": 80864, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 30, "quality_score": 65, "study_goal": "The researchers aimed to determine the efficacy and acceptability of melatonin for treating mood disorders, including bipolar disorder, unipolar depression, and seasonal affective disorder.", "results_summary": "The study found no significant evidence for melatonin's effect on improving mood symptoms, though acceptability and tolerability were good. Results were inconclusive due to small sample sizes and methodological differences, justifying further research.", "population_specificity": "Patients with mood disorders (bipolar disorder, unipolar depression, seasonal affective disorder).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:10.082817+00:00"}
{"study_id": 80863, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of the neuroimmunoendocrine (NIE) modulatory network, including dopamine-melatonin imbalance, in the pathogenesis and progression of Parkinson's disease (PD).", "results_summary": "The study suggests that dopamine-melatonin imbalance in the retino-diencephalic/mesencephalic-pineal axis may explain motor complications during dopamine replacement therapy in PD, and the NIE network could underlie non-motor symptoms like circadian rhythm and sleep disorders.", "population_specificity": "Patients with Parkinson's disease (PD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:10.219402+00:00"}
{"study_id": 80866, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate whether melatonin could reduce or prevent premature ovarian failure in female chemotherapy patients.", "results_summary": "The study suggests melatonin may be useful for preventing premature ovarian failure in chemotherapy-treated patients, acting as an antioxidant and adjuvant. It also notes that other adjuvants are being developed for similar purposes.", "population_specificity": "Pre-menopausal female cancer patients undergoing chemotherapy.", "effective_dosage": "Not Assessed", "study_duration": "Not Assessed", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:10.626811+00:00"}
{"study_id": 80867, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the complex interaction between the circadian clock, melatonin, and the immune system in maintaining normal pregnancy.", "results_summary": "The study suggests that irregular melatonin production may disrupt immune cell function and vascular support for placentation, highlighting melatonin's potential role in circadian regulation of pregnancy.", "population_specificity": "Pregnant individuals and fetal-maternal immune interactions.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:10.889180+00:00"}
{"study_id": 80865, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 65, "study_goal": "To study the effect of melatonin as an adjuvant therapy in the treatment of neonatal sepsis.", "results_summary": "After 24 and 72 hours of melatonin administration, both groups improved, with the intervention group showing significantly greater improvement in clinical condition, hs-CRP, and serum parameters compared to the control group.", "population_specificity": "40 neonates with neonatal sepsis (20 in intervention group, 20 in control group) from the Neonatal Intensive Care Unit, Menoufia University Hospitals.", "effective_dosage": "20 mg as a single dose.", "study_duration": "Single dose, followed by monitoring at 24 and 72 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:11.747062+00:00"}
{"study_id": 80868, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review melatonin's effects on rheumatoid arthritis (RA) and osteoarthritis (OA), focusing on its regulatory role in inflammatory pathways and circadian rhythms, as well as its potential protective effects on disease pathogenesis.", "results_summary": "Melatonin modulates inflammatory pathways and circadian clock genes (e.g., BMAL, CRY, DEC2), influencing cartilage destruction/regeneration in RA and OA. It exhibits cytoprotective effects through NF-\u03baB signaling and receptor-mediated actions, suggesting potential therapeutic benefits.", "population_specificity": "Patients with rheumatoid arthritis (RA) and osteoarthritis (OA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:14.154643+00:00"}
{"study_id": 80869, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the role of melatonin among other hormones, genes, and lifestyle factors in the onset and progression of vitiligo.", "results_summary": "The abstract mentions melatonin as one of the suspected drivers of vitiligo but does not provide specific findings regarding its effects.", "population_specificity": "Not specified (general discussion of vitiligo pathology).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:14.413422+00:00"}
{"study_id": 80873, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were examining the role of oxidative stress in intestinal pathologies and the potential involvement of endogenous antioxidant defense systems like glutathione (GSH).", "results_summary": "The abstract discusses oxidative stress in the intestine due to ROS and RNS imbalance, particularly under aging or exacerbated conditions, but does not mention Melatonin or its effects.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:19.024305+00:00"}
{"study_id": 80870, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential mechanisms of melatonin's anticancer activities in ovarian cancer cells and experimental models.", "results_summary": "Melatonin exhibits pro-oxidant, anti-proliferative, anti-angiogenic, and immunomodulatory properties in ovarian cancer cells, differentially regulating signaling pathways involved in apoptosis, survival, inflammation, proliferation, and metabolism. Clinical studies suggest a negative correlation between melatonin levels and ovarian cancer aggressiveness.", "population_specificity": "Ovarian cancer cells (in vitro and in vivo models) and clinical studies involving ovarian cancer patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:19.834753+00:00"}
{"study_id": 80874, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to compare sleep and circadian variability in adults with delayed sleep-wake phase disorder (DSWPD) to healthy controls, and assess the impact of sleep variability on the timing of melatonin treatment.", "results_summary": "People with DSWPD had more variable wake times and total sleep time than healthy controls, and greater sleep variability was associated with larger shifts in the dim light melatonin onset (DLMO). The DLMO was relatively stable in controls but showed more variability in DSWPD patients.", "population_specificity": "Adults with delayed sleep-wake phase disorder (DSWPD) and healthy controls.", "effective_dosage": "Not specified", "study_duration": "Ten-day protocol with four days of analyzed sleep data.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:20.497060+00:00"}
{"study_id": 80871, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to clarify melatonin's protective effect against UVR-induced skin damage in laboratory and clinical settings, assess its efficacy against natural sun exposure, and evaluate cognitive dysfunction with full-body application.", "results_summary": "Melatonin showed a protective effect against UVR-induced erythema, particularly at 12.5% concentration, with no significant cognitive dysfunction observed. However, results were mixed in participants without erythema reactions, and further long-term studies are needed.", "population_specificity": "Humans exposed to UVR (both artificial and natural sunlight)", "effective_dosage": "0.5%, 2.5%, and 12.5% topical melatonin", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:20.624867+00:00"}
{"study_id": 80876, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review sleep disorders as a public health issue and discuss advances in pharmacotherapy, including potential new targets like the melanin-concentrating hormone system.", "results_summary": "The abstract does not specifically discuss Melatonin's effects but highlights general advances in sleep disorder management and emerging drug targets.", "population_specificity": "Not specified", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:21.083742+00:00"}
{"study_id": 80875, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of melatonin in preventing sleep-related injuries in patients with rapid eye movement sleep behavior disorder (RBD).", "results_summary": "Melatonin (3-12 mg) was found to be effective in limiting injury potential in RBD patients, alongside clonazepam (0.5-2.0 mg). The abstract highlights the need for further evidence-based studies to refine prognostic predictions and explore neuroprotective therapies.", "population_specificity": "Patients with rapid eye movement sleep behavior disorder (RBD), including idiopathic and symptomatic cases, often associated with synucleinopathy neurodegeneration.", "effective_dosage": "3-12 mg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:21.314168+00:00"}
{"study_id": 80877, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the pharmacological and physiological effects of melatonin, including its role in circadian rhythm regulation and potential therapeutic applications.", "results_summary": "Melatonin exhibits diverse physiological effects, including antioxidant actions, immune regulation, and protective effects on the brain and cardiovascular system. It also shows potential as a biomarker and therapeutic agent for various disorders.", "population_specificity": "Newborns, children, and adults (broad review, not specific to a single population).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:22.926335+00:00"}
{"study_id": 80878, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the state of sleep science in children with ASD, propose reasons for high insomnia prevalence, and present a practice pathway for improving sleep, including the use of melatonin.", "results_summary": "The study found that melatonin, alongside sleep education, environmental changes, and behavioral interventions, has strong evidence for promoting sleep in children with ASD. The practice pathway developed by the ATN Sleep Committee integrates these approaches.", "population_specificity": "Children with autism spectrum disorder (ASD) and chronic insomnia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:27.473311+00:00"}
{"study_id": 80879, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review the potential therapeutic effects of melatonin hybrids for treating neurodegenerative diseases.", "results_summary": "The abstract highlights melatonin's pleiotropic actions in preventing neuroinflammation, oxidative stress, excitotoxicity, and apoptosis, which are key processes in neurodegeneration. It also discusses melatonin hybrids derived from compounds like tacrine, berberine, and curcumin as potential treatments for neurodegenerative disorders.", "population_specificity": "Not specified (general focus on neurodegenerative disorders)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:27.812216+00:00"}
{"study_id": 80882, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effectiveness of melatonin in treating insomnia among patients with schizophrenia spectrum disorders.", "results_summary": "The study found that melatonin yielded significant results in short-term trials, improving both subjective and objective insomnia symptoms in patients with schizophrenia.", "population_specificity": "Patients with schizophrenia spectrum disorders experiencing insomnia.", "effective_dosage": "Not specified", "study_duration": "Short-term (exact duration not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:28.007692+00:00"}
{"study_id": 80881, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to investigate the role of melatonin in preventing and managing radio and/or chemotherapy-induced mucositis in cancer patients.", "results_summary": "The study suggests melatonin is an effective alternative therapy for preventing and managing mucositis, potentially improving the quality of life for cancer patients undergoing radio/chemotherapy.", "population_specificity": "Cancer patients undergoing radio and/or chemotherapy, specifically those at risk of mucositis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:28.075463+00:00"}
{"study_id": 80880, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to explore the bidirectional relationship between sleep and epilepsy, including the role of melatonin and other neurotransmitters in regulating sleep-wake behavior and potential antiepileptic effects.", "results_summary": "The study found that melatonin, along with other neurotransmitters, regulates sleep-wake behavior and may have antiepileptic effects. It also noted that drugs influencing the sleep-wake cycle could serve as potential antiseizure agents.", "population_specificity": "Not specified (general discussion of sleep and epilepsy interactions).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:28.262833+00:00"}
{"study_id": 80872, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of oral melatonin compared to midazolam in reducing preoperative anxiety in children undergoing elective surgery and assessing compliance during anesthesia induction.", "results_summary": "Melatonin was as effective as midazolam in reducing children's preoperative anxiety and improving compliance during anesthesia induction, with no significant differences between the two treatments.", "population_specificity": "Children undergoing elective surgery (80 participants, 40 per group).", "effective_dosage": "0.5 mg/kg (max 20 mg), single oral dose.", "study_duration": "Single dose administered preoperatively.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:29.184646+00:00"}
{"study_id": 80883, "supplement_id": 1328, "safety_score": "90", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the therapeutic functions of melatonin in various sleep disorders and compare its safety and efficacy to existing pharmaceutical treatments.", "results_summary": "Melatonin was found to synchronize circadian rhythms, improve sleep onset, duration, and quality, and had no obvious short- or long-term adverse effects. It offers a safer alternative to current sleep medications with fewer side effects.", "population_specificity": "Individuals with sleep disorders (insomnia, sleep-related breathing disorders, hypersomnolence, circadian rhythm sleep-wake disorders, and parasomnias).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:30.496413+00:00"}
{"study_id": 80884, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the therapeutic effects of melatonin on axonal tract injury in rodent models of intracerebral hemorrhage (ICH).", "results_summary": "Melatonin was shown to produce therapeutic effects in rodent models of ICH, particularly in mitigating injury to the internal capsule, though specific efficacy details were not elaborated. The abstract suggests melatonin may help address compromised axonal transport and structural fragmentation.", "population_specificity": "Rodent models of intracerebral hemorrhage (ICH).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:30.629614+00:00"}
{"study_id": 80885, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the success of interventions, including pharmacological substitution with melatonin, in reducing benzodiazepine and Z-drug use in older adults.", "results_summary": "One study employing pharmacological substitution with melatonin achieved a 64.3% benzodiazepine discontinuation rate. Clinical outcomes following discontinuation were mostly unchanged, with no difference in withdrawal symptoms or sleep quality in most studies.", "population_specificity": "Older adults (\u226565 years)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:35.150066+00:00"}
{"study_id": 80889, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers reviewed the pathophysiological processes in recurrent major depressive disorder (rMDD), including the role of decreased melatonergic pathway activity.", "results_summary": "The abstract highlights that decreased melatonergic pathway activity is one of the biochemical changes associated with rMDD, but it does not provide specific findings on melatonin's effects.", "population_specificity": "Patients with recurrent major depressive disorder (rMDD).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:35.498561+00:00"}
{"study_id": 80890, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review published literature on melatonin's use in dental diseases, focusing on periodontal diseases and dental implantology, and summarize its potential effects.", "results_summary": "Melatonin demonstrated beneficial immunological, anti-oxidant, and anti-inflammatory effects in dental disorders, particularly in periodontal disease and dental implant osseointegration, though further research is needed to understand its exact mechanisms.", "population_specificity": "Not specified (literature review)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:35.985908+00:00"}
{"study_id": 80886, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether elevated endogenous melatonin concentrations impair glucose tolerance when eating late, particularly in carriers of the MTNR1B risk allele.", "results_summary": "The study found that late dinner timing, coinciding with elevated melatonin levels, impaired glucose tolerance, with a stronger effect in MTNR1B risk-carriers. Eating late significantly impaired glucose tolerance only in risk-carriers, not in non-carriers.", "population_specificity": "Participants included homozygous carriers and non-carriers of the MTNR1B risk allele.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:36.044742+00:00"}
{"study_id": 80887, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore melatonin's regulatory roles in DNA damage response (DDR) and DNA repair pathways and its potential to enhance the efficacy of DNA-damaging agents in cancer therapy.", "results_summary": "Melatonin was found to regulate DDR at multiple levels and improve the efficacy of DNA-damaging agents in cancer therapy, with potential benefits across various DNA repair mechanisms such as HR, NHEJ, BER, NER, and MMR.", "population_specificity": "Not specified (general discussion of mechanisms, not a clinical trial)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:36.961469+00:00"}
{"study_id": 80891, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate melatonin's role in mitigating cancer at various stages, its mechanisms of action, and its potential clinical applications, including enhancing conventional cancer therapies.", "results_summary": "Melatonin shows inhibitory effects on cancer initiation, progression, and metastasis, improves sensitivity to conventional drugs, and reduces treatment toxicity. Its actions involve both receptor-mediated and direct intracellular mechanisms.", "population_specificity": "Cancer patients (various types, with emphasis on breast cancer)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:38.033670+00:00"}
{"study_id": 80893, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the molecular and cellular mechanisms linking neurological disorders and sleep disturbances using zebrafish as a model, with a focus on conserved regulators like melatonin.", "results_summary": "The abstract highlights that zebrafish models show conserved sleep/wake cycle regulators, including melatonin, and identifies novel sleep-regulating proteins. Sleep deficiencies were observed in zebrafish models of neuropsychiatric disorders, suggesting potential links between these conditions and sleep phenotypes.", "population_specificity": "Zebrafish models of genetic neuropsychiatric disorders (e.g., psychomotor retardation, autism, anxiety disorders).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:39.392292+00:00"}
{"study_id": 80892, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the anticancer efficacy of melatonin based on epidemiological, experimental, and clinical studies, with a focus on its mechanisms of action.", "results_summary": "Melatonin demonstrated growth inhibition in human tumor cells in vitro and in animal models, with mechanisms including antioxidant activity, modulation of melatonin receptors, stimulation of apoptosis, and inhibition of angiogenesis and metastasis. It also showed potential as an adjuvant in cancer therapies by enhancing therapeutic effects and reducing side effects of chemotherapy or radiation.", "population_specificity": "Human tumor cells (in vitro), animal models, and general cancer populations (breast, prostate, gastric, colorectal cancers).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:39.494499+00:00"}
{"study_id": 80894, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to assess the safety, tolerability, and efficacy of melatonin for treating behavioral insomnia in children with ADHD.", "results_summary": "Melatonin showed improvements in sleep-onset latency and total sleep duration, was well tolerated with mild to moderate adverse events, and had varying study quality from moderate to low.", "population_specificity": "Children with ADHD and associated sleep problems.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:42.029429+00:00"}
{"study_id": 80896, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to explore the role of melatonin and other receptors in depression and antidepressant-like effects.", "results_summary": "The abstract discusses melatonin's potential involvement in depression mechanisms but does not provide specific results on its efficacy or outcomes. It highlights the complexity of depression and the need for innovative treatments.", "population_specificity": "Not specified (general discussion of depression mechanisms).", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:43.501342+00:00"}
{"study_id": 80895, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to test the biochemical effects of melatonin supplementation in ICU patients with decreased blood melatonin levels.", "results_summary": "Melatonin supplementation increased serum melatonin levels significantly four hours after the first administration, and the study evaluated its impact on total antioxidant capacity and oxidative stress, though specific results for these outcomes are not detailed in the abstract.", "population_specificity": "Intensive Care Unit (ICU) patients", "effective_dosage": "3 mg twice daily (at 20:00 and 24:00)", "study_duration": "From the evening of the 3rd ICU day until discharge", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:43.585278+00:00"}
{"study_id": 80898, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate whether melatonin reduces the frequency of nocturia episodes in MS patients and its potential impact on LUTS, fatigue, cognition, and quality of life.", "results_summary": "The study design suggests melatonin may reduce nocturia episodes and improve related symptoms, but specific results are not provided in the abstract. Secondary outcomes include quality of life, sleep quality, and urinary tract symptoms.", "population_specificity": "Progressive Multiple Sclerosis (MS) patients with moderate-to-severe nocturia.", "effective_dosage": "2 mg at bedtime.", "study_duration": "Two six-week treatment phases with a one-month wash-out period.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:45.375226+00:00"}
{"study_id": 80900, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the potential roles of melatonin in preventing and treating liver injuries and diseases, focusing on its mechanisms of action.", "results_summary": "Melatonin demonstrated regulatory effects on various molecular pathways (inflammation, proliferation, apoptosis, metastasis, autophagy) and showed potential for preventing and treating liver injuries and diseases.", "population_specificity": "Not specified (review of existing studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:46.312623+00:00"}
{"study_id": 80899, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether melatonin could reduce weight gain in adolescents with bipolar disorder taking olanzapine and lithium carbonate.", "results_summary": "Melatonin coadministration showed marginally significant reductions in BMI and body weight gain compared to placebo, though results did not reach full statistical significance. The differences between groups were consistent but modest in magnitude.", "population_specificity": "11-17-year-old bipolar I disorder patients", "effective_dosage": "Not specified", "study_duration": "12 weeks", "interactions": "Coadministered with olanzapine and lithium carbonate", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:46.497722+00:00"}
{"study_id": 80901, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of CYP1B1 in regulating endogenous metabolic pathways, including melatonin metabolism, and its potential as a therapeutic target for metabolic diseases.", "results_summary": "The study found that CYP1B1 is involved in melatonin metabolism and interacts with nuclear receptors to maintain homeostasis of endogenous compounds, suggesting its modulation could have therapeutic implications for metabolic diseases.", "population_specificity": "Not specified (general metabolic pathways and enzyme interactions)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:46.628984+00:00"}
{"study_id": 80897, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to assess the feasibility of a trial testing whether melatonin (at 0.5 mg or 2 mg doses) can prevent delirium in critically ill patients compared to placebo.", "results_summary": "The abstract does not report results, as it describes a feasibility trial for a future study. Outcomes to be measured include protocol adherence, pharmacokinetics, delirium incidence, sleep quality, and clinical outcomes.", "population_specificity": "Critically ill patients aged 18+ with an expected ICU stay >48 hours, recruited from 3 Canadian ICUs.", "effective_dosage": "0.5 mg and 2 mg melatonin, administered for up to 14 days.", "study_duration": "Maximum of 14 days.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:47.437436+00:00"}
{"study_id": 80903, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to identify genetic loci associated with male-pattern baldness (MPB) through a large GWAS meta-analysis.", "results_summary": "The study identified 63 MPB-associated loci from a meta-analysis of 10,846 early-onset cases and 11,672 controls across eight cohorts. The findings highlight the genetic basis of MPB but do not address melatonin's role or effects.", "population_specificity": "Males with early-onset male-pattern baldness and controls from eight independent cohorts.", "effective_dosage": "Not available", "study_duration": "Not applicable (genetic association study)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:51.681383+00:00"}
{"study_id": 80902, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate melatonin's neuroprotective functions in Alzheimer's disease (AD) pathogenesis, focusing on its role in modulating amyloidogenic and nonamyloidogenic processing of \u03b2-amyloid precursor protein.", "results_summary": "Melatonin was found to stimulate nonamyloidogenic processing and inhibit amyloidogenic processing of \u03b2APP by activating \u03b1-secretases and downregulating \u03b2- and \u03b3-secretases at the transcriptional level, suggesting potential benefits in AD progression. The study highlights melatonin's role in early detection and treatment as an anti-AD therapy.", "population_specificity": "Cellular and animal models, and clinical interventions in AD patients.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:51.746405+00:00"}
{"study_id": 80905, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the development of precision medicine in circadian rhythm sleep-wake disorders, including the use of biomarkers, phenotyping, and technology, but did not specifically focus on Melatonin.", "results_summary": "The abstract discusses the complexity of circadian rhythm sleep-wake disorders and the need for advanced technology and biomarkers to improve precision medicine, but does not report specific findings about Melatonin.", "population_specificity": "Not specified (general discussion of circadian rhythm sleep-wake disorders).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:53.391716+00:00"}
{"study_id": 80909, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to review nanocarrier strategies for dermal melatonin delivery and assess its potential biomedical and cosmetic applications.", "results_summary": "The review found that nanoplatforms like liposomes and polymeric nanoparticles enhance melatonin's dermal delivery by preventing premature oxidation and improving skin permeation, with promising in vitro and in vivo results.", "population_specificity": "Not specified (review of existing literature).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:54.883024+00:00"}
{"study_id": 80906, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers sought to evaluate the efficacy and safety/tolerability of oral medications and dietary supplements, including melatonin, for the treatment of melasma.", "results_summary": "Melatonin, among other oral agents, showed a beneficial effect on melasma improvement, with efficacy and tolerability demonstrated across the included RCTs. Adverse events were minimal in severity and frequency.", "population_specificity": "Patients with melasma (specific demographics not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:55.131087+00:00"}
{"study_id": 80908, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 70, "quality_score": 90, "study_goal": "The researchers aimed to investigate whether prophylactic treatment with melatonin could prevent depression, anxiety, and sleep disturbances in patients following acute coronary syndrome (ACS).", "results_summary": "The study did not report specific results in the abstract, but it evaluated the potential preventive effect of melatonin on depressive symptoms, anxiety, and sleep disturbances using a randomized, placebo-controlled design. The abstract highlights melatonin's low toxicity and its anxiolytic and hypnotic effects as potential advantages.", "population_specificity": "Patients with ACS and no depressive symptoms.", "effective_dosage": "25 mg melatonin.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:55.185102+00:00"}
{"study_id": 80907, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of melatonin and tasimelteon in entraining the circadian clock in individuals with Non-24-h sleep-wake disorder (non-24).", "results_summary": "Melatonin and tasimelteon were found to entrain the circadian clock, improving night-time sleep and daytime alertness. The timing of administration was critical, with optimal effects observed when administered 6 h before bedtime for most individuals or at wake time for those with shorter circadian periods.", "population_specificity": "Totally blind individuals (lacking conscious light perception) with Non-24-h sleep-wake disorder.", "effective_dosage": "0.5 mg melatonin (small, non-soporific doses).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:35:56.269067+00:00"}
{"study_id": 80910, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 45, "study_goal": "The researchers aimed to analyze the prevalence of associated neurological disorders in RBD patients and evaluate the effectiveness of treatments, including melatonin.", "results_summary": "Melatonin was used in 9% of RBD patients, but the abstract does not provide specific efficacy data or outcomes for melatonin compared to other treatments like clonazepam.", "population_specificity": "33 RBD patients (13 women, 20 men) with a mean age of 62.72 years, some with mild cognitive impairment.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:00.118423+00:00"}
{"study_id": 80911, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the protective effects of melatonin against septic injury by reviewing published literature on its use in experimental and clinical sepsis.", "results_summary": "Melatonin demonstrated antioxidative and anti-inflammatory actions, showing promise in treating sepsis by resisting bacterial pathogens and protecting against septic injury through multiple molecular mechanisms.", "population_specificity": "Experimental and clinical sepsis cases (animals and humans).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:00.425581+00:00"}
{"study_id": 80912, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review melatonin's potential as a reprogramming strategy to prevent developmental origins of health and disease (DOHaD)-related non-communicable diseases (NCDs) by examining its mechanisms and roles in pregnancy and fetal development.", "results_summary": "The study highlights melatonin's pleiotropic bioactivities and its interrelation with mechanisms underlying developmental programming, supporting its potential as a reprogramming therapy. Animal models suggest multifunctional roles for melatonin, but human studies are needed to bridge the translational gap.", "population_specificity": "Animal models and theoretical human applications (developmental programming context).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:01.902686+00:00"}
{"study_id": 80913, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to determine whether melatonin's antioxidant properties could mitigate exercise-induced oxidative stress and muscle damage in athletes.", "results_summary": "The study found that high-dose melatonin administration improved the circadian system in athletes, suggesting potential benefits against oxidative stress and muscle damage, though specific results are not detailed in the abstract.", "population_specificity": "Athletes (24 participants)", "effective_dosage": "100 mg/day", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:02.027974+00:00"}
{"study_id": 80915, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to assess whether melatonin could mitigate cyclosporine-induced ER stress, matrix protein expression, and mitochondrial dysfunction in human gingival fibroblasts.", "results_summary": "Melatonin significantly reduced cyclosporine-augmented ER stress markers and matrix protein expression in human gingival fibroblasts, though its effect was less pronounced than 4PBA.", "population_specificity": "Human gingival fibroblasts (HGF) in vitro.", "effective_dosage": "Not specified", "study_duration": "24 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:02.062183+00:00"}
{"study_id": 80914, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to review the analgesic properties of Melatonin, particularly focusing on the role of MT2 receptors in preclinical and clinical pain conditions.", "results_summary": "Melatonin demonstrated significant analgesic effects in various pain models (chronic, acute, inflammatory, neuropathic), primarily mediated by MT2 receptors. Selective MT2 partial agonists (UCM924, UCM765) showed higher potency than Melatonin without causing sedation or motor impairments.", "population_specificity": "Preclinical animal models and clinical studies (specific human populations not detailed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:03.169735+00:00"}
{"study_id": 80916, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize current knowledge on melatonin's neuroprotective effects in experimental models of hemorrhagic stroke and explore its underlying mechanisms.", "results_summary": "The study found that melatonin exhibits neuroprotective effects in hemorrhagic stroke models through antioxidant, anti-apoptotic, and anti-inflammatory mechanisms, suggesting its potential as a therapeutic candidate.", "population_specificity": "Experimental models of hemorrhagic stroke (subarachnoid hemorrhage and intracerebral hemorrhage).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:03.612391+00:00"}
{"study_id": 80918, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 65, "study_goal": "The researchers aimed to identify factors associated with medication use, including melatonin, during recovery from sports-related concussions in adolescents.", "results_summary": "Melatonin was among the medications prescribed to adolescents with persistent post-concussion symptoms, particularly headache, but its specific efficacy was not detailed in the abstract.", "population_specificity": "Adolescents aged 12-18 years who sustained sports-related concussions.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:07.773789+00:00"}
{"study_id": 80917, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the relationship between melatonin and sirtuins, particularly SIRT1 and SIRT3, focusing on its differential effects in normal versus cancer cells.", "results_summary": "Melatonin was found to increase sirtuin activity, especially SIRT1, in various cells and animal models, but showed inhibitory effects in some tumor cells, highlighting a dichotomy in its actions. The study suggests melatonin's potential role in modulating sirtuins for cytoprotective effects in aging, neurodegenerative diseases, and cancer.", "population_specificity": "Various cells and animal models (not human-specific).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:08.165003+00:00"}
{"study_id": 80923, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the role of Melatonin in regulating physiopathological events associated with brain ischemia.", "results_summary": "The abstract does not provide specific findings regarding Melatonin's effects.", "population_specificity": "Not specified", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:09.537649+00:00"}
{"study_id": 80919, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of mitochondrial bioenergetic dysregulation in bipolar disorder and identify potential treatment targets, though Melatonin was not specifically mentioned in the abstract.", "results_summary": "The study discussed increased mitochondrial respiration and ATP production in bipolar mania, contrasting with decreased function in depression, but did not directly address Melatonin's effects.", "population_specificity": "Patients with bipolar disorder (mania, euthymia, and depressive phases).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:10.177021+00:00"}
{"study_id": 80921, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the self-perceived efficacy and tolerability of melatonin and other treatments in children and adolescents with primary headaches.", "results_summary": "Melatonin was used by 10% of subjects for both migraine and tension-type headache, with good perceived efficacy and tolerability. The study did not provide detailed statistical analysis or comparative effectiveness data for melatonin.", "population_specificity": "Children and adolescents (mean age 12 years) diagnosed with primary headaches (migraine or tension-type headache).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:10.178565+00:00"}
{"study_id": 80920, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential benefits of melatonin in treating experimental models of uveitis and optic neuritis by examining its anti-inflammatory and antioxidant effects.", "results_summary": "Melatonin demonstrated efficacy in reducing oxidative and nitrosative damage, tumor necrosis factor, and prostaglandin levels in the retina and optic nerve, while also preventing functional and structural damage from inflammation and suppressing active inflammatory responses.", "population_specificity": "Experimental models (not human subjects) of uveitis and optic neuritis.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:11.462453+00:00"}
{"study_id": 80922, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the role of melatonin receptor agonists, like ramelteon, in the management of insomnia among chronic orofacial pain patients.", "results_summary": "The study suggests that melatonin receptor agonists, including ramelteon, are among the FDA-approved pharmacological options for treating insomnia, which can subsequently improve chronic orofacial pain. Non-pharmacological therapies are recommended first, but pharmacological options like ramelteon are considered effective when needed.", "population_specificity": "Chronic orofacial pain patients with insomnia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:11.488632+00:00"}
{"study_id": 80904, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review melatonin's anti-inflammatory properties and its potential role in managing inflammatory responses during and after radiotherapy.", "results_summary": "The abstract suggests melatonin has notable anti-inflammatory properties that may help regulate inflammatory signaling pathways in both tumor and normal tissues, potentially improving radiotherapy outcomes. However, specific clinical results or statistical significance are not detailed.", "population_specificity": "Not specified (general review of literature on radiotherapy and inflammation).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:12.662984+00:00"}
{"study_id": 80924, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the effectiveness of melatonin as a dietary supplement for individuals with spinal cord injury (SCI).", "results_summary": "The study found low-quality evidence that does not permit assessment of melatonin's effectiveness in individuals with SCI. No specific outcomes or benefits were reported.", "population_specificity": "Individuals with spinal cord injury (SCI).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:15.852254+00:00"}
{"study_id": 80925, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate melatonin's preclinical profile as a potential pharmacological treatment for anxiety disorders like PTSD, focusing on its effects on fear conditioning and extinction.", "results_summary": "Melatonin impaired contextual fear conditioning (hippocampus-dependent) but facilitated cued fear extinction when administered before extinction training, without affecting acquisition or expression. It was ineffective when given immediately after extinction training.", "population_specificity": "Rats (preclinical study)", "effective_dosage": "Single administration 30 minutes before conditioning/extinction training (specific dosage not mentioned)", "study_duration": "Not specified (single administration)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:16.334891+00:00"}
{"study_id": 80928, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to summarize the mechanisms of Cyclophosphamide-induced toxicity on the male reproductive system and explore methods to prevent or restore these effects.", "results_summary": "The study found that Cyclophosphamide primarily induces oxidative stress and alters gene expression in spermatocytes, but these effects can be mitigated by compounds with antioxidant properties or those targeting biochemical alterations.", "population_specificity": "Male mice, rats, and humans.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:17.032708+00:00"}
{"study_id": 80926, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 90, "study_goal": "The researchers aimed to determine whether prophylactic melatonin decreases the rate of delirium in critically ill adults compared to placebo.", "results_summary": "The study did not report specific results in the abstract, but it is designed to evaluate delirium rates, sleep quality, and other outcomes in ICU patients. The trial is noted as the largest evaluation of melatonin for delirium prevention in this population.", "population_specificity": "Critically ill adults in intensive care units (ICUs) with an expected ICU stay of 72 hours or more.", "effective_dosage": "4 mg enterally once daily at 21:00.", "study_duration": "Until ICU discharge or 14 days after enrolment, whichever occurs first.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:17.819678+00:00"}
{"study_id": 80927, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize recent advances in melatonin's biological role in stem cells and discuss its potential applications in stem cell-based therapy.", "results_summary": "Melatonin was found to promote stem cell proliferation, migration, and differentiation, showing therapeutic potential in various diseases through its anti-oxidant, anti-inflammatory, anti-apoptosis, and anti-ageing properties. Combining melatonin with stem cell transplantation demonstrated promising results in neurodegenerative diseases, liver cirrhosis, wound healing, and other conditions.", "population_specificity": "Stem cells in various disease models (neurodegenerative diseases, liver cirrhosis, wound healing, myocardial infarction, kidney ischemia injury, osteoporosis).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:18.541223+00:00"}
{"study_id": 80929, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether melatonin could sensitize leukemia lymphocytes to anticancer drugs and clarify the role of reactive oxygen species (ROS) in apoptosis induction.", "results_summary": "Melatonin showed synergistic cytotoxicity with new-generation anticancer drugs in leukemia lymphocytes but additive or antagonistic effects with conventional drugs. It reduced ROS levels and minimized side-effects in leukemia cells without affecting normal lymphocytes.", "population_specificity": "Leukemia lymphocytes and normal lymphocytes.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Combinations with doxorubicin, everolimus, and barasertib were studied.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:18.727529+00:00"}
{"study_id": 80931, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize the mechanisms by which melatonin may mitigate the cardiotoxic effects of aluminium phosphide (AlP) poisoning on cardiac mitochondria.", "results_summary": "Melatonin was found to mitigate respiratory chain complex inhibition, increase ATP generation, inhibit mitochondrial permeability transition pore (mPTP) opening, prevent apoptosis, and hinder cytochrome c release, promoting cell survival in AlP-induced cardiotoxicity.", "population_specificity": "Patients with acute aluminium phosphide poisoning (theoretical or preclinical focus, not explicitly stated).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:20.748802+00:00"}
{"study_id": 80930, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers were investigating the effects of transcranial photobiomodulation (tPBM) using red/near-infrared light on cognitive function in chronic traumatic brain injury (TBI) patients.", "results_summary": "The study found that tPBM improved mitochondrial function, increased ATP production, and enhanced regional blood flow in the brain, leading to cognitive improvements in chronic TBI patients. The treatment was nonthermal, painless, and noninvasive.", "population_specificity": "11 chronic TBI patients with long-lasting cognitive dysfunction caused by various accidents (motor vehicle, sports-related, blast injuries).", "effective_dosage": "Not specified (LED cluster head: 5.35 cm diameter, 500 mW, 22.2 mW/cm\u00b2).", "study_duration": "6 weeks (18 outpatient treatments, Monday/Wednesday/Friday).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:21.904225+00:00"}
{"study_id": 80932, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 20, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of melatonin for treating sleep onset or sleep maintenance insomnia in adults.", "results_summary": "The study suggests that clinicians should not use melatonin as a treatment for sleep onset or sleep maintenance insomnia in adults, based on weak evidence and low certainty of its efficacy.", "population_specificity": "Adults with chronic insomnia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:22.197435+00:00"}
{"study_id": 80933, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential benefits of Melatonin for sleep disorders in COPD patients, focusing on its hypnotic and antioxidant effects.", "results_summary": "The study found that Melatonin may provide mild hypnotic and antioxidant benefits for COPD patients with sleep disorders, without associated respiratory failure or worsening respiratory symptoms.", "population_specificity": "COPD patients with sleep disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:22.821745+00:00"}
{"study_id": 80935, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the mechanisms by which melatonin enhances memory performance, focusing on its effects in rodents.", "results_summary": "Melatonin modulates the conversion of newly acquired information into long-term memory and reduces memory deficits in elderly people and animal models, though the exact mechanisms remain unclear.", "population_specificity": "Rodents and elderly humans (indirectly referenced).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:24.515187+00:00"}
{"study_id": 80934, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore melatonin's potential as a chronotherapeutic drug for metabolic disease, focusing on its role in glucose homeostasis and type 2 diabetes management.", "results_summary": "The study found that melatonin influences insulin secretion, hepatic glucose metabolism, and insulin sensitivity, with lower night-time melatonin levels linked to increased type 2 diabetes risk. Reduced melatonin levels and receptor mutations are associated with higher diabetes risk, suggesting therapeutic potential.", "population_specificity": "Individuals with type 2 diabetes and metabolic dysfunction, as well as healthy individuals for comparison.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:24.815708+00:00"}
{"study_id": 80937, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the effects of melatonin on neural stem cells (NSCs) in various physiological and pathological conditions, focusing on its potential neuroprotective and therapeutic roles.", "results_summary": "The study suggests melatonin may exert neuroprotective effects in CNS diseases like Parkinson's and Alzheimer's by influencing NSC proliferation and differentiation, indicating potential therapeutic benefits for neural injury and neurodegenerative disorders.", "population_specificity": "Not specified (review of existing literature on neural stem cells and melatonin effects).", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:26.074622+00:00"}
{"study_id": 80936, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to compare the long-term effects of neutral and blue-blocking intraocular lenses on circadian photoentrainment and sleep, including melatonin secretion, in cataract surgery patients.", "results_summary": "Blue-blocking IOLs increased sleep efficiency but reduced nocturnal melatonin secretion by 50% compared to neutral IOLs. Cataract surgery improved ipRGC response and overall sleep quality, though the effect on sleep may not be linked to circadian photoentrainment.", "population_specificity": "67 patients with age-related cataract", "effective_dosage": "Not specified", "study_duration": "1 year after surgery", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:26.391835+00:00"}
{"study_id": 80938, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to explore the physiological connection between the central nervous system and the skin, focusing on how neurohormones like melatonin influence human scalp hair follicles.", "results_summary": "The study found that human scalp hair follicles respond to and produce various neurohormones, including melatonin, which play roles in regulating growth, pigmentation, energy metabolism, and immune status. It highlights the potential of targeting these pathways for therapeutic applications in dermatology.", "population_specificity": "Human scalp hair follicles (in vitro or preclinical research context).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:28.926783+00:00"}
{"study_id": 80939, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to investigate whether clonal haemopoiesis increases the risk of therapy-related myeloid neoplasms in cancer patients, with a secondary analysis involving a trial comparing chemotherapy with or without melatonin.", "results_summary": "The study found that clonal haemopoiesis was associated with a higher risk of therapy-related myeloid neoplasms, but the abstract does not report specific outcomes related to melatonin's efficacy or safety.", "population_specificity": "Patients with lymphoma treated in a randomized trial of front-line chemotherapy with or without melatonin.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:29.815249+00:00"}
{"study_id": 80941, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 35, "quality_score": 65, "study_goal": "The researchers aimed to determine whether melatonin influences body weight in human subjects by conducting a systematic review of controlled trials.", "results_summary": "The study found no strong or significant effect of melatonin on body weight, though some trials reported slight increases or decreases. Subgroup analysis suggested melatonin might be more effective in children and adolescents, potentially buffering weight fluctuations.", "population_specificity": "244 patients across 7 clinical trials, with subgroup analysis focusing on children and adolescents.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:30.285458+00:00"}
{"study_id": 80940, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the potential benefits of melatonin as a co-adjuvant treatment in gastrointestinal diseases, particularly IBS, Crohn's disease, ulcerative colitis, and necrotizing enterocolitis.", "results_summary": "Melatonin acts as a powerful antioxidant, modulates immune responses, and influences gut motility, with low doses accelerating intestinal transit and high doses potentially decreasing motility. It shows promise as a co-adjuvant treatment for various gastrointestinal disorders.", "population_specificity": "Patients with gastrointestinal diseases (IBS, Crohn's disease, ulcerative colitis, necrotizing enterocolitis).", "effective_dosage": "Not specified (mentions low vs. high doses but no exact amounts).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:30.935568+00:00"}
{"study_id": 80943, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate melatonin as a potential neuroprotective treatment for neonates with hypoxic ischemic encephalopathy (HIE).", "results_summary": "The abstract suggests melatonin is considered a supportive option to enhance the neuroprotective effects of therapeutic hypothermia, targeting free radical reduction, anti-inflammatory, and anti-apoptotic actions. However, specific results regarding melatonin's efficacy are not detailed.", "population_specificity": "Term-born infants with moderate to severe HIE.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:32.022370+00:00"}
{"study_id": 80942, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to explore the biological underpinnings of CNS disorders and psychiatric conditions, focusing on the role of melatonin synthesis and its interactions with immune-inflammatory processes.", "results_summary": "The study highlights that alterations in melatonin synthesis due to immune-inflammatory processes may impact immune cell reactivity and contribute to CNS and psychiatric disorders. It suggests targeting gut-related factors and immune regulators could lead to novel treatments for these conditions.", "population_specificity": "Not specified (general discussion of CNS disorders and psychiatric conditions, with focus on Alzheimer's disease and major depressive disorder).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:32.199093+00:00"}
{"study_id": 80944, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore melatonin's neuroprotective, anti-inflammatory, and antioxidant properties, as well as its role in mitochondrial homeostasis and dopaminergic neuron survival.", "results_summary": "Melatonin demonstrated neuroprotective, anti-inflammatory, and antioxidant effects, acted as a free-radical scavenger, improved mitochondrial function, and regulated neurotrophin expression to support dopaminergic neuron survival.", "population_specificity": "Not specified (general biological mechanisms discussed).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:33.044705+00:00"}
{"study_id": 80945, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review neuroendocrine abnormalities in Parkinson's disease, including melatonin secretion disruption, and explore their clinical implications and potential as targets for neuroprotective therapies.", "results_summary": "The abstract highlights that neuroendocrine abnormalities, including melatonin disruption, are common in Parkinson's disease and associated with non-motor symptoms, but it does not provide specific findings on melatonin's effects.", "population_specificity": "Patients with Parkinson's disease.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:33.411852+00:00"}
{"study_id": 80946, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 60, "quality_score": 75, "study_goal": "The researchers sought to determine the effect of walnuts, which contain melatonin among other compounds, on mood in healthy volunteers.", "results_summary": "No significant mood changes were observed overall or in females, but a medium effect size improvement in Total Mood Disturbance score was noted (-27.49%).", "population_specificity": "64 college students (healthy volunteers)", "effective_dosage": "Not specified", "study_duration": "8 weeks per intervention phase, with a 6-week washout period", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:35.856085+00:00"}
{"study_id": 80948, "supplement_id": 1328, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate melatonin's potential as a neuroprotective agent in newborns, focusing on its antioxidant and neuromodulatory effects.", "results_summary": "Preclinical and limited clinical studies suggest melatonin offers neuroprotective benefits for newborns, particularly in cases of preterm birth and neonatal asphyxia. The review highlights promising safety and pharmacokinetic data, with ongoing clinical trials further investigating its efficacy.", "population_specificity": "Newborns, particularly those at risk of brain injury due to preterm birth or neonatal asphyxia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:37.960094+00:00"}
{"study_id": 80949, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effect of natalizumab on melatonin levels in relapsing-remitting multiple sclerosis (RR-MS) patients and its relation to disease status.", "results_summary": "Melatonin levels were decreased in RR-MS patients but returned to normal levels after 56 weeks of natalizumab treatment.", "population_specificity": "12 relapsing-remitting multiple sclerosis (RR-MS) patients and 12 healthy controls.", "effective_dosage": "300 mg of natalizumab every 4 weeks.", "study_duration": "56 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:38.187434+00:00"}
{"study_id": 80951, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The study does not focus on Melatonin; it examines the role of perivascular adipose tissue (PVAT) dysfunction in obesity-induced vascular complications.", "results_summary": "The study does not report any findings related to Melatonin.", "population_specificity": "Diet-induced obese mice and obese individuals with gluteal/visceral fat biopsy samples.", "effective_dosage": "Not available", "study_duration": "Not available", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:38.522608+00:00"}
{"study_id": 80947, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the interactions between neurotrophic factors, the HPA-axis, and circadian rhythm, focusing on alterations in melatonin release in Huntington's disease (HD) and its potential therapeutic implications.", "results_summary": "The study found that HD is associated with altered melatonin release, which may negatively impact BDNF expression and contribute to neuropathological and clinical features. Multidisciplinary therapy was suggested as a non-pharmaceutical approach to restore balance in these pathways.", "population_specificity": "Individuals with Huntington's disease (HD), including pre-symptomatic stages.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:39.420980+00:00"}
{"study_id": 80950, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to evaluate melatonin's potential benefits in attenuating, reducing, or preventing symptoms of sarcopenia, osteoporosis-related sarcopenia, and age-related neuromuscular junction dysfunction.", "results_summary": "The study suggests melatonin may be beneficial in addressing sarcopenia symptoms due to its antioxidant and free radical scavenging properties, with potential applications in related dysfunctions. Findings indicate a high safety profile and reduced melatonin levels in advanced age.", "population_specificity": "Aging population, particularly those with sarcopenia, osteoporosis-related sarcopenia, and age-related neuromuscular junction dysfunction.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:39.633008+00:00"}
{"study_id": 80952, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the role of the frontal cortex in mood and cognition regulation and identify improved treatments for depression and related disorders.", "results_summary": "The study highlighted the importance of microdialysis in quantifying neuromodulators in the frontal cortex, revealing complex interactions among monoaminergic pathways and leading to novel multi-target drugs for depression.", "population_specificity": "Freely-moving rodents", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:39.946859+00:00"}
{"study_id": 80953, "supplement_id": 1328, "safety_score": "70", "efficacy_score": 40, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the safety and efficacy of melatonin as an off-label treatment for insomnia in older adults.", "results_summary": "The study found that melatonin has a small impact on sleep latency but can produce residual sedation. It is noted as an unregulated product with limited efficacy compared to other treatments.", "population_specificity": "Older adults with insomnia.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:40.600384+00:00"}
{"study_id": 80954, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine if prolonged-release melatonin could stabilize disrupted rest-activity cycles in medicated patients with severe mental illness and if benzodiazepine dose reduction affected circadian rhythm parameters.", "results_summary": "Melatonin significantly increased interdaily stability and trended toward reducing intradaily variability compared to placebo. Benzodiazepine tapering was not linked to circadian rhythm changes but showed a non-significant increase in activity counts.", "population_specificity": "Medicated patients with severe mental illness.", "effective_dosage": "2 mg prolonged-release melatonin.", "study_duration": "24 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:43.828180+00:00"}
{"study_id": 80956, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential role of melatonin in enhancing stem cell survival and functional integrity, particularly in ischemia-related conditions.", "results_summary": "The study found that melatonin-supported stem cell therapy outperformed stem cell therapy alone in improving ischemia-related organ dysfunction by reducing oxidative stress and inflammation. Melatonin was shown to stabilize cell membranes and enhance tissue regeneration.", "population_specificity": "Not specified (general focus on ischemia-related conditions)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:45.513963+00:00"}
{"study_id": 80955, "supplement_id": 1328, "safety_score": "85", "efficacy_score": 30, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the efficacy and safety of intravenous and intracoronary melatonin in reducing reperfusion injury in STEMI patients undergoing revascularization.", "results_summary": "Melatonin did not significantly reduce infarct size compared to placebo and showed unfavorable effects on ventricular volumes and LVEF recovery. However, it demonstrated no toxicity at the doses used, with comparable adverse event rates between groups.", "population_specificity": "Patients presenting with STEMI within 6 hours of chest pain onset undergoing primary percutaneous coronary intervention (PPCI).", "effective_dosage": "Intravenous and intracoronary melatonin (specific dosage not detailed in abstract).", "study_duration": "Intervention administered during PPCI, with follow-up assessments at 6 \u00b1 2 days and 130 \u00b1 10 days post-PPCI.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:46.893025+00:00"}
{"study_id": 80957, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the role of melatonin in treating rapid eye movement sleep behavior disorder (RBD) and its association with neurodegenerative diseases.", "results_summary": "Melatonin (3-6 mg before bed) was found to be an effective treatment for RBD, reducing sleep-related injury and dream enactment behaviors. The study highlights its potential as a reversible treatment option for RBD, though long-term outcomes were not detailed.", "population_specificity": "Individuals with rapid eye movement sleep behavior disorder, particularly those over 60 years old.", "effective_dosage": "3-6 mg before bed", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:46.930244+00:00"}
{"study_id": 80958, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine melatonin's immunoregulatory role, its dual effects on inflammation, and its potential therapeutic use in inflammatory diseases.", "results_summary": "Melatonin acts as an \"immunological buffer,\" enhancing immunity in immunosuppression and suppressing overactive immune responses. It mediates between neurohormonal and immune systems via the immune-pineal axis, with potential therapeutic benefits in inflammatory diseases.", "population_specificity": "Not specified (general immune system mechanisms discussed).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:47.081054+00:00"}
{"study_id": 80959, "supplement_id": 1328, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review current advances in understanding the molecular mechanisms by which melatonin counteracts tumor metastases, focusing on experimental and clinical observations.", "results_summary": "The study highlights melatonin's oncostatic properties, including its ability to interfere with tumor metastases through mechanisms like modulation of cell interactions, extracellular matrix remodeling, and angiogenesis. The evidence supports melatonin's potential role in controlling metastatic diseases.", "population_specificity": "Not specified (review of experimental and clinical studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T21:36:47.364245+00:00"}
